Ascend Wellness Holdings (AAWH) Income from Non-Controlling Interests (2020)
Ascend Wellness Holdings (AAWH) posted quarterly Income from Non-Controlling Interests of $501000.0 for Q3 2020, down 32.02% quarter-over-quarter from $737000.0 in Q2 2020.
Ascend Wellness Holdings (AAWH) Income from Non-Controlling Interests (2020) Analysis & Trends
Ascend Wellness Holdings' Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $501000.0 for Q3 2020.
- In Q3 2020, Income from Non-Controlling Interests changed N/A year-over-year to $501000.0; the TTM figure through Jun 2021 stood at $501000.0 (changed N/A YoY), while the FY2020 annual figure was $1.6 million, up 218.63% from the prior year.
- Income from Non-Controlling Interests for Q3 2020 stood at $501000.0, down from $737000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $737000.0 in Q2 2020, with the low at $360000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ascend Wellness Holdings | 85.26 Mn | 18.26 Mn | 45.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 501,000.00 |
| Jun 30, 2020 | 737,000.00 |
| Mar 31, 2020 | 360,000.00 |